Chronic Coronary Artery Disease Companion to Braunwald's Heart Disease
Material type:
- 616.1/23--dc23
- NLM WG 300
- RC685.C6
Item type | Current library | Collection | Call number | Status | Barcode | |
---|---|---|---|---|---|---|
E-BOOKS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | NFIC | 616.1/23 (Browse shelf(Opens below)) | 2 | EBS11707 |
Contents:
I Introduction
II Pathogenesis
III Clinical Evaluation
IV Management
V Prevention
Index
IBC
Featuring expert guidance from Drs. James de Lemos and Torbjørn Omland, as well as other globally known leaders in cardiology, Chronic Coronary Artery Disease covers every aspect of managing and treating patients suffering from chronic coronary syndromes. This brand-new companion to Braunwald's Heart Disease was designed as a stand-alone reference for physicians treating patients who present with complex, unique challenges, offering the latest information on the use of imaging modalities in diagnosis and treatment, advances in interventional and surgical approaches to revascularization, new medications to improve symptoms and outcomes in chronic CAD, and much more.
Covers every aspect of evaluation and treatment of patients who suffer from chronic coronary syndromes.
Provides both evidenced based recommendations from the most recent guidelines from the major cardiology societies: AHA, ACC, and ESC, as well as practical management tips from leading experts with extensive clinical experience.
Highlights new developments concerning epidemiology and prevention, pathophysiology, and clinical findings, as well as laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, and prognosis and management of chronic coronary syndromes.
Features information on today's hot topics, including the use of novel imaging modalities in diagnosis and treatment and emerging therapies to improve outcomes in chronic CAD. Common terms and phrases: abnormal activity acute addition American angina angiography assessment associated benefit blood CABG cardiac Cardiol Cardiovasc cardiovascular cause cells changes chest cholesterol chronic Circulation clinical compared controlled coronary artery disease death decrease depression diabetes dose drug dysfunction effects et al evaluation evidence exercise factors failure flow function genetic glucose greater guidelines Health heart disease higher imaging implantable important improve increased indicate individuals intervention ischemia ischemic JAm Coll Cardiol lead less levels limited lower major measured mechanisms meta-analysis microvascular mortality myocardial infarction normal obesity obstructive outcomes pain patients perfusion population prediction pressure prevention primary randomized recommended reduced region reserve response revascularization risk risk factors score severe showed significant Society stable statin stent stress symptoms syndrome testing therapy tion treated treatment trial vascular ventricular versus women
There are no comments on this title.